Stock data
Adaptive Biotechnologies Corporation (ADPT)
Adaptive Biotechnologies Corporation (ADPT) reported revenue of US$276.98M and net income of -US$59.50M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$276.98M | — | -US$57.12M | -US$59.50M | — |
| 2024 | US$178.96M | — | -US$162.55M | -US$159.49M | — |
| 2023 | US$170.28M | — | -US$227.03M | -US$225.25M | — |
| 2022 | US$185.31M | — | -US$200.19M | -US$200.19M | — |
| 2021 | US$154.34M | — | -US$208.97M | -US$207.28M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$71.55M | -US$39.79M | — |
| 2026-03-31 | US$70.87M | -US$20.03M | — |
| 2025-12-31 | US$71.68M | -US$13.58M | — |
| 2025-09-30 | US$93.97M | US$9.55M | — |
| 2025-06-30 | US$58.88M | -US$25.61M | — |
| 2025-03-31 | US$52.44M | -US$29.85M | — |
| 2024-12-31 | US$47.46M | -US$33.69M | — |
| 2024-09-30 | US$46.44M | -US$32.07M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.